R
René Adam
Researcher at Université Paris-Saclay
Publications - 634
Citations - 44864
René Adam is an academic researcher from Université Paris-Saclay. The author has contributed to research in topics: Liver transplantation & Transplantation. The author has an hindex of 92, co-authored 578 publications receiving 37929 citations. Previous affiliations of René Adam include University of Padua & University of Paris.
Papers
More filters
Journal ArticleDOI
A Model to Predict Significant Macrosteatosis in Hepatic Grafts.
Ahmed Swelam,René Adam,René Adam,Lelde Lauka,Luiza Basilio Rodrigues,Sherif Elgarf,Mylène Sebagh,Nicolas Golse,Antonio Sa Cunha,Antonio Sa Cunha,Daniel Cherqui,Daniel Cherqui,Denis Castaing,Denis Castaing,Marc-Antoine Allard,Marc-Antoine Allard +15 more
TL;DR: A model to predict significant macrosteatosis based on noninvasive methods, including L / S ratio, BMI, and history of alcohol, might be helpful to refine indication for liver biopsy before donation after brain death.
Journal ArticleDOI
Adjuvant Gemcitabine-Oxaliplatin (GeMOX) after Curative Surgery in High-risk Patients with Cholangiocarcinoma:
Bernard Paule,Paola Andreani,Marie-Pierre Bralet,Catherine Guettier,Catherine Guettier,René Adam,René Adam,Denis Castaing,Denis Castaing,Daniel Azoulay,Daniel Azoulay +10 more
TL;DR: Adjuvant chemotherapy with GEMOX alone seems ineffective in intrahepatic and hilar CCA with a high risk of relapse, suggesting a clinical applicability of EGFR inhibitors in CCA.
Journal ArticleDOI
Large hepatocellular carcinoma: Does fibrosis really impact prognosis after resection?
Nicolas Golse,A. El Bouyousfi,F. Marques,B. Bancel,Kayvan Mohkam,Christian Ducerf,P. Merle,Mylène Sebagh,Denis Castaing,A. Sa Cunha,René Adam,Daniel Cherqui,Eric Vibert,J.-Y. Mabrut +13 more
TL;DR: In this article, the authors compared predictors of survival in patients with and without cirrhosis following hepatectomy for large hepatocellular carcinoma (LHCC) ≥ 5 cm.
Journal ArticleDOI
Optimizing FOLFIRINOX tolerability in patients with colorectal cancer through dosing irinotecan in the morning for men and in the afternoon for women.
Francis Lévi,Annabelle Ballesta,Abdoulaye Karaboué,Qi Huang,C. N. J. Focan,Philippe Chollet,Mohamed Bouchahda,René Adam,Carlo Garufi,Pasquale F. Innominato +9 more
TL;DR: Iinotecan toxicity was worse in female (F) than in male (M) patients on FOLFIRI for metastatic colorectal cancer (MCC) and this finding could reflect different optimal admittance levels.
Journal ArticleDOI
Original and generic preservation solutions in organ transplantation. A new paradigm
Joan Roselló-Catafau,Arnau Panisello-Roselló,Gianfranco Pasut,Miquel Navasa,Jacques Pirenne,René Adam +5 more
TL;DR: The recent emergence of generic versions of organ preservation solutions (solutions with the same composition and under the same legislation as the original versions, but with different brands) compelled the study whether the standards are maintained when comparing the original and its generic counterpart.